Cadrenal Therapeutics Inc (CVKD) Stock Price, Quote & News

Company Profile

Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company focuses on developing therapeutics for rare cardiovascular conditions. The company is developing Tecarfarin, a novel oral and reversible anticoagulant to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation, such as patients with left ventricular assist devices, end-stage kidney disease, atrial fibrillation, and thrombotic anti-...

Industry: Biotechnology

Sector: Healthcare

Phone: 904 300 0701

Website: www.cadrenal.com

Address:

822 A1A North, Suite 306, Ponte Vedra, United States

BioTuesdays Dec. 11 at 8:17 PM

$CVKD announced the acquisition of VLX-1005—a first-in-class, Phase 2 12-LOX inhibitor—along with additional 12-lipoxygenase (12-LOX) assets from closely held Veralox Therapeutics, for the treatment of heparin-induced thrombocytopenia (HIT) https://biotuesdays.com/2025/12/11/cadrenal-acquires-vlx-1005-for-patients-with-hit/

0 · Reply

JOINTRADING_GROUP Dec. 11 at 8:15 PM

$AMC $CVKD $SMX $SLV The bullish trend is self-reinforcing, attracting more capital into the market.

0 · Reply

ardobbins Dec. 11 at 7:39 PM

$CVKD I was promised Lambo if I bought at $12...

0 · Reply

LimitWatcherX_1524 Dec. 11 at 4:03 PM

$CVKD biotech microcap, needs clean base and nearby catalyst to justify taking the volatility

0 · Reply

Gdoubleup Dec. 11 at 3:56 PM

$BEAT woe nelly! 😆 🤣 I also see some #moonrocks in $CVKD volume will be the mover foe sho 👌 IMO

0 · Reply

Gdoubleup Dec. 11 at 3:53 PM

$CVKD I'd like a Double Double Animal Style here...30.00 tp...imo

0 · Reply

Gdoubleup Dec. 11 at 3:49 PM

$CVKD

0 · Reply

mebanks Dec. 11 at 2:40 PM

$CVKD ; wall at $12 is with armed guards, dogs, camera, laser, hard to pass

0 · Reply

Vaderesking Dec. 11 at 1:49 PM

We post everyday, it’s free, we do not sell anything, we do it to better our own skillsets. Please hold us accountable. $SPY Oh boy, post rate cut hangover? Watch this 686.86, we need it for the upcoming week. If we do not get over this level throughout intraday trading, then you should expect another 680.XX visit, in my opinion. $NQ As per the above, we need over 25713.75 for any type of bull trend formation after this 25393.50 visit, we might actually revisit the latter level if we do not get over 25713.75. $QQQ Expecting this to recede back into this 621.14 zone if we cannot get over 625.80. $RTY This is a strong trend, tailwind to the broader market, money is flowing into small caps, I’d watch pump discords (not condoning it), for quick scalps. Note $CVKD $MIGI on watch

0 · Reply

frankyboyz Dec. 11 at 1:48 PM

11.50 tight sl not getting love right now... let c $CVKD Cadrenal Therapeutics Acquires VLX-1005, a First-in-Class Phase 2 12-LOX Inhibitor for Patients with Heparin-Induced Thrombocytopenia (HIT) https://news.nuntiobot.com/article/0be641d2-8a6b-441f-a7c8-738bdab0bff1 says: It is the first and only potent, highly selective inhibitor of human 12-LOX in clinical testing, distinguishing it from related compounds. max 10% risk for me on this

0 · Reply